Immunofuse

Research - , ,

Immunofuse Employees
Roger Swartz

Chief Executive Officer

Contact Roger Swartz

Contact All Immunofuse Employees
Immunofuse Senior Management
Roger Swartz

Chief Executive Officer

Contact Roger Swartz

Contact All Immunofuse Employees
Immunofuse Details

At Immunofuse we are focused on A New Immunization Modality against Type I Hypersensitivity, Respiratory Viruses, HIV, H. Pylori, Cancer , Ebola, Eosinphilic Esophagitis, Novel and Reinvigorated Antibody Programs, Cancer that enter through the mucosa. Our main focus is the episomal or genomic expression via gene therapy of Dimeric Immunoglobulin A1 (dIgA1) which, becomes secretory immunoglobulin A1 (SIgA1) as part of traversing the epithelium into the mucus. Our gene therapy can work for all including adults of older age and persons with underlying medical conditions because we bypass the adaptive immune system.

Immunofuse logo, Immunofuse contact details
Website:
Employees: 1
HQ:
Location: , ,
Revenue:

Contacting Immunofuse: Connect with Executives and Employees

Get in Touch with Immunofuse Executives and Employees

Connecting with Immunofuse's Executives and Workforce

Accessing Contact Information for Immunofuse Executives

Connecting with Immunofuse: Reach Out to Their Team

Discover How to Contact Immunofuse Executives and Staff

Looking to connect with Immunofuse executives or employees?

Seeking to Get in Touch with Immunofuse Executives or Staff?

Want to Reach Out to Immunofuse Executives or Team Members?

In Search of Contact Details for Immunofuse Professionals?

Connecting with Immunofuse: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z